Hashimoto K, London E D
Neuroimaging and Drug Action Section, National Institute on Drug Abuse, Baltimore, MD 21224.
Eur J Pharmacol. 1993 May 12;236(1):159-63. doi: 10.1016/0014-2999(93)90241-9.
This study was undertaken to examine further the pharmacology of [3H]ifenprodil binding in rat brain at 37 degrees C. [3H]Ifenprodil bound specifically to membranes (Kd = 5.09 +/- 0.30 nM; Bmax = 2.36 +/- 0.19 pmol/mg protein). [3H]Ifenprodil binding was potently inhibited by sigma ligands and inhibitors of cytochrome P-450. The levorotatory enantiomers of pentazocine and SKF 10,047 were more potent inhibitors than corresponding dextrorotatory enantiomers. Furthermore, the pharmacological profile of [3H]ifenprodil binding was highly correlated with that of sigma 2 sites, not sigma 1 sites. The results suggest that [3H]ifenprodil labels sigma 2 sites in rat brain at 37 degrees C, and that [3H]ifenprodil would be useful for studying sigma receptor subtypes.
本研究旨在进一步考察37℃时大鼠脑中[3H]艾芬地尔结合的药理学特性。[3H]艾芬地尔特异性结合于膜上(解离常数Kd = 5.09±0.30 nM;最大结合量Bmax = 2.36±0.19 pmol/mg蛋白质)。[3H]艾芬地尔的结合受到σ配体和细胞色素P - 450抑制剂的强烈抑制。喷他佐辛和SKF 10,047的左旋对映体比相应的右旋对映体是更强效的抑制剂。此外,[3H]艾芬地尔结合的药理学特征与σ2位点高度相关,而非σ1位点。结果表明,37℃时[3H]艾芬地尔标记大鼠脑中的σ2位点,且[3H]艾芬地尔将有助于研究σ受体亚型。